After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Avidity Biosciences Inc is $7.14B. A total of 1.26 million shares were traded on the day, compared to an average of 3.28M shares.
In the most recent transaction, Mosbrooker Eric sold 6,562 shares of RNA for 45.38 per share on Oct 03 ’25. After the transaction, the Chief Commercial Officer now owns 55,000 company shares. In a previous transaction on Sep 22 ’25, Hughes Steven George sold 2,208 shares at 40.58 per share. RNA shares that Chief Medical Officer owns now total 38,867.
Among the insiders who sold shares, McCarthy Teresa disposed of 15,000 shares on Sep 15 ’25 at a per-share price of $41.41. This resulted in the Chief Human Resources Officer holding 97,130 shares of RNA after the transaction. In another insider transaction, Hughes Steven George sold 1,542 shares at $45.41 per share on Sep 15 ’25. Company shares held by the Chief Medical Officer now total 38,867.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RNA has a high of $56.00 and a low of $21.51.
As of this writing, RNA has an earnings estimate of -$1.18 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of -$0.61 per share and a lower estimate of -$1.78. The company reported an EPS of -$0.65 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RNA’s latest balance sheet shows that the firm has $405.54M in Cash & Short Term Investments as of fiscal 2021. There were $11.73M in debt and $29.66M in liabilities at the time. Its Book Value Per Share was $9.87, while its Total Shareholder’s Equity was $381.43M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
